Evidence map›Paper›PMID 35366909›Full record

ArticleJournal of translational medicine2022

Correction to: Deconvolution of sarcoma methylomes reveals varying degrees of immune cell infiltrates with association to genomic aberrations.

Malte Simon, Sadaf S Mughal, Peter Horak, Sebastian Uhrig, Jonas Buchloh, Bogac Aybey, Albrecht Stenzinger, Hanno Glimm, Stefan Fröhling, Benedikt Brors and 1 more

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of translational medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 59% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Malte Simon *Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Sadaf S Mughal *Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Peter HorakDivision of Translational Medical Oncology, National Center for Tumor Diseases, German Cancer Research Center, Heidelberg, Germany.
Sebastian UhrigDivision of Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Jonas BuchlohDivision of Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Bogac AybeyDivision of Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Albrecht StenzingerInstitute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
Hanno GlimmDepartment of Translational Medical Oncology, NCT Dresden, Dresden, Germany.
Stefan FröhlingDivision of Translational Medical Oncology, National Center for Tumor Diseases, German Cancer Research Center, Heidelberg, Germany.
Benedikt BrorsDivision of Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Charles D ImbuschDivision of Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany. charles@imbusch.net.ORCID https://orcid.org/0000-0003-4920-551X
German Cancer Research Center · DEHeidelberg University · DENational Center for Tumor Diseases · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35366909
PMCPMC8977019
OpenAlexW4226185146

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.